Table 2 |
||||
|
Patients' HER2 immunohistochemistry score in the TMAs represented by a range and maximum spot value |
||||
|
VE1range |
VE1max |
|||
|
0/1+ |
2+ |
3+ |
Total |
|
|
|
||||
|
0 |
136 |
4 |
16 |
156 |
|
1 |
0* |
4 |
0 |
4 |
|
2 |
0* |
0* |
1 |
1 |
|
|
||||
|
VE2range |
VE2max |
|||
|
0/1+ |
2+ |
3+ |
Total |
|
|
|
||||
|
0 |
129 |
6 |
16 |
151 |
|
1 |
0* |
9 |
1 |
10 |
|
2 |
0 |
0* |
0 |
0 |
|
|
||||
|
DArange |
DAmax |
|||
|
1 |
2 |
3 |
Total |
|
|
|
||||
|
0 |
122 |
3 |
16 |
141 |
|
1 |
0* |
16 |
3 |
19 |
|
2 |
0* |
0* |
1 |
1 |
|
|
||||
|
* the range cannot logically be 1 or 2. The cross tabulation of the patients' HER2 score range and maximum values represents variation of the analysis results between individual patient's spots. VE1max and VE2max - first and second visual evaluation by the pathologist, DAmax - digital analysis score. Accordingly, VE1range, VE2range, and DArange represent range between a minimum and maximum spot HER2 score value. |
||||
|
Laurinaviciene et al. Diagnostic Pathology 2011 6:87 doi:10.1186/1746-1596-6-87 |
||||
